Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.84M Buy
13,752
+31
+0.2% +$11.1K 1.34% 15
2025
Q4
$4.49M Buy
13,721
+2,530
+23% +$803K 1.21% 18
2025
Q3
$3.16M Sell
11,191
-1,336
-11% -$387K 0.85% 28
2025
Q2
$3.5M Buy
12,527
+1,178
+10% +$334K 1.01% 25
2025
Q1
$3.54M Buy
11,349
+422
+4% +$125K 1.11% 22
2024
Q4
$2.85M Buy
10,927
+307
+3% +$91.1K 0.92% 29
2024
Q3
$3.42M Buy
10,620
+442
+4% +$145K 1.12% 23
2024
Q2
$3.18M Buy
10,178
+637
+7% +$187K 1.17% 21
2024
Q1
$2.71M Buy
9,541
+1,347
+16% +$394K 1.01% 23
2023
Q4
$2.36M Buy
8,194
+539
+7% +$147K 0.98% 24
2023
Q3
$2.06M Buy
7,655
+1,533
+25% +$383K 0.87% 25
2023
Q2
$1.6M Buy
6,122
+1,626
+36% +$377K 0.69% 26
2023
Q1
$1.09M Buy
4,496
+1,545
+52% +$379K 0.54% 31
2022
Q4
$775K Buy
2,951
+535
+22% +$143K 0.41% 31
2022
Q3
$545K Buy
2,416
+1,715
+245% +$416K 0.32% 29
2022
Q2
$171K Buy
701
+551
+367% +$135K 0.1% 48
2022
Q1
$36K Hold
150
0.02% 109
2021
Q4
$34K Buy
+150
New +$31.7K 0.02% 106

Other funds holding AMGN

PYA Waltman Capital's AMGN Position: Q1 2026 in Review

PYA Waltman Capital increased its Amgen (AMGN) stake by 0.23% in Q1 2026, buying an estimated $11.1K and bringing the position to 13,752 shares worth $4.84M. The position accounts for 1.34% of the portfolio, ranked #15.

PYA Waltman Capital first reported a position in AMGN in Q4 2021 and has held it in 18 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • PYA Waltman Capital held 13,752 shares of Amgen worth $4.84M as of Q1 2026.
  • PYA Waltman Capital bought 31 Amgen shares in Q1 2026, an estimated $11.1K.
  • Amgen made up 1.34% of PYA Waltman Capital's portfolio in Q1 2026, its #15 holding.
  • PYA Waltman Capital first reported a position in Amgen in Q4 2021 and has held it in 18 quarters since.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on PYA Waltman Capital's 13F filing for Q1 2026, filed 13 May 2026.